The Kratom Council

Latest / Regulation

Regulation

Montana Tabled Its Kratom Consumer Protection Act For Not Being Strict Enough. A Ban Bill Advanced Instead.

A closed manila folder pushed to the edge of an old legislative desk while a second folder lies open under a brass lamp, an empty chamber behind.

The usual shape of a state kratom fight is a consumer-protection bill on one side and opposition on the other. Montana has produced something different. Over five days, two interim committees of the same Legislature took up the same subject and moved in opposite directions — and the consumer-protection bill was not defeated by people who wanted less regulation. It was tabled, in part, by legislators who wanted more.

What The Two Committees Did

On Tuesday, September 1, the Law and Justice Interim Committee tabled a Kratom Consumer Protection Act on an 8–1 vote, the Daily Montanan reported. The measure would have banned synthesized kratom, imposed labeling requirements, allowed the state to regulate and test kratom products, and restricted sales to buyers 18 and older.

Days earlier, on the reporting of Yellowstone Public Radio, the Economic Affairs Interim Committee had gone the other way, voting 6–5 to advance draft legislation that would ban kratom statewide by designating its chemical compounds as controlled substances. That vote moves the draft closer to consideration in the 2027 legislative session.

Neither committee has enacted anything. Interim committees in Montana prepare legislation for a session that does not convene until next year, and both measures remain drafts. What the two votes establish is not law but posture: the body that handles criminal justice declined to advance a regulatory framework, and the body that handles commerce advanced a prohibition.

Why The Consumer-Protection Bill Failed

The reasons given were not uniform, and that is the most instructive part of the record.

Sen. Ellie Boldman, a Missoula Democrat, described her position bluntly. “I voted to ban Kratom because ‘gas station heroin’ has no business being in Montana,” she said.

Sen. Vince Ricci, a Livingston Republican, objected on a narrower ground: the bill would have set the purchase age at 18, while Montana restricts tobacco, cannabis and alcohol to 21. That is an internal-consistency argument about age thresholds rather than a judgment about the plant, and it is one that has surfaced in other states as well — Minnesota raised its kratom purchase age to 21 earlier this cycle.

Testimony ran in both directions. Dr. Lauren Wilson, a former president of the Montana chapter of the American Academy of Pediatrics, told the committee she had treated a newborn who required morphine following the mother’s kratom use during pregnancy. Drenda Niemann of the Association of Montana Public Health Officials raised concerns about addiction, withdrawal and unknown long-term impacts. On the other side, Casey Hugs, a kratom advocate, argued for the product’s potential as a harm-reduction alternative for people with heroin addiction. Those are the witnesses’ characterizations, offered in a public hearing and reported here as testimony; this publication does not adopt any of them.

The Industry Position, And The Cost Argument

At the Economic Affairs hearing, the split was framed less around health than around money and scope.

EJ Redding of the Montana Kava & Kratom Association made the industry’s now-standard argument for separating the categories: “By removing the synthesized products from the market, we do away with the vast majority of problems we have seen here.”

Amanda Cahill of the Confluence Public Health Alliance, speaking for county health departments, pressed the opposite concern — that regulating carries its own price. “The fiscal note that I handed out does put a lot of financial burden on tax payers to go ahead and regulate and legitimize a product in Montana,” she said.

That second argument is worth isolating, because it is not the familiar one. It holds that a regulatory regime is not merely weaker than prohibition but affirmatively costly — that the state would be spending money to build testing and oversight machinery for a product it could instead simply prohibit. Wherever a Kratom Consumer Protection Act carries a fiscal note, that argument is available to its opponents, and Montana is the clearest instance yet of it being made.

A Second Montana Track

The state Legislature is not the only body in Montana that has taken this up. This publication reported earlier on the Blackfeet Nation’s move to ban kratom, an action taken under tribal authority and entirely independent of the interim committees. A tribal prohibition and a state prohibition are separate legal instruments with separate jurisdictional reach, and neither determines the other. But both are live in the same state in the same year.

What Happens Next

Nothing binding until 2027. Both drafts are headed toward a session that has not begun, and a tabled bill can be revived, rewritten or replaced before then. The Daily Montanan reported general agreement among the legislators that the state needs to act on kratom in the 2027 session; what it does not report is agreement on which direction that action runs.

For anyone tracking state legislation, the Montana record is a useful correction to a common assumption. A Kratom Consumer Protection Act is often described as the industry-friendly outcome and a ban as the adverse one, with the fight running between them. In Montana this round, the consumer-protection bill’s most consequential opposition came from legislators who considered it too permissive — and the prohibition draft is the one still moving.

What This Report Does Not Establish

Both measures are committee drafts, not enacted law, and neither has been voted on by the full Legislature. This publication did not attend either hearing and reports the votes, testimony and quotations as they appear in the sources listed below; it has not reviewed the bill text of either draft directly. Descriptions of what the drafts would do are as reported.

Statements in this report about kratom’s effects, risks or uses — including all hearing testimony — are the characterizations of the named witnesses and legislators who made them. This publication does not adopt or endorse them, and takes no position on the merits of either draft.

Sources

  1. Daily Montanan — “Legislators eye reining in ‘Wild West’ kratom industry” (September 1, 2026), reporting the Law and Justice Interim Committee’s 8–1 vote to table the Kratom Consumer Protection Act and the hearing testimony
  2. Yellowstone Public Radio — “Montana lawmakers advance bill to ban psychoactive plant” (August 28, 2026), reporting the Economic Affairs Interim Committee’s 6–5 vote and witness statements
  3. Daily Inter Lake — “Montana lawmakers look to regulate kratom ahead of 2027 session” (January 20, 2026), background on the interim process
  4. The Kratom Council — “Montana Tribe Moves To Ban Kratom: A Closer Look At The Blackfeet Nation’s Decision”
  5. The Kratom Council — “Minnesota Kratom Purchase Age Rises To 21”
  6. The Kratom Council — “States Take Different Paths On Kratom Regulation”

← Back to all coverage

Get new reporting by email